Prostate Cancer - Results from #23940

Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy - Abstract March 4, 2013

Ability of preoperative 3.0-Tesla magnetic resonance imaging to predict the absence of side-specific extracapsular extension of prostate cancer - Abstract March 4, 2013

From bevacizumab to tasquinimod: Angiogenesis as a therapeutic target in prostate cancer - Abstract March 4, 2013

A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons - Abstract March 4, 2013

The Prostate Cancer Journey: Results of an online survey of men and their partners - Abstract March 4, 2013

Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret - Abstract March 2, 2013

Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: A propensity-score-matching analysis - Abstract March 2, 2013

Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer - Abstract March 2, 2013

Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective - Abstract March 2, 2013

Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance - Abstract March 2, 2013

Fostering informed decisions: A randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer - Abstract March 1, 2013

Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer - Abstract March 1, 2013

Management of castration-resistant prostate cancer: A global approach - Abstract March 1, 2013

Salvage radiotherapy outcomes for biochemical recurrence following radical prostatectomy among the African-Caribbean population of Guadeloupe - Abstract March 1, 2013

Assays for prostate cancer: Changing the screening paradigm? - Abstract March 1, 2013

Androgen deprivation therapy in advanced prostate cancer: Is intermittent therapy the new standard of care? - Abstract March 1, 2013

Targeting the androgen receptor in the management of castration-resistant prostate cancer: Rationale, progress, and future directions - Abstract March 1, 2013

The importance of local control in high-risk locally advanced prostate cancer - Abstract March 1, 2013

Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy - Abstract March 1, 2013

Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer - Abstract March 1, 2013

Page 1198 of 1447